Your Input: | |||||
MAP2K4 | Mitogen-activated protein kinase kinase 4; Belongs to the protein kinase superfamily. (463 aa) | ||||
H3BFZ2_LATCH | BHLH domain-containing protein. (165 aa) | ||||
H3BFW7_LATCH | BHLH domain-containing protein. (161 aa) | ||||
WNT2B | Protein Wnt; Ligand for members of the frizzled family of seven transmembrane receptors; Belongs to the Wnt family. (370 aa) | ||||
ANXA6 | Annexin. (662 aa) | ||||
LOC102352268 | Transforming growth factor beta; Belongs to the TGF-beta family. (414 aa) | ||||
OSTN | Osteocrin. (136 aa) | ||||
RARG | Retinoic acid receptor gamma. (389 aa) | ||||
H3B938_LATCH | Teneurin N-terminal domain-containing protein. (181 aa) | ||||
WNT2 | Protein Wnt; Ligand for members of the frizzled family of seven transmembrane receptors; Belongs to the Wnt family. (358 aa) | ||||
H3B6N2_LATCH | Teneurin N-terminal domain-containing protein. (214 aa) | ||||
FXN | Frataxin. (194 aa) | ||||
AR | Androgen receptor. (412 aa) | ||||
NKX2-5 | NK2 homeobox 5. (296 aa) | ||||
STC1 | Stanniocalcin 1. (250 aa) | ||||
AKAP13 | PH domain-containing protein. (644 aa) | ||||
FGF7 | Fibroblast growth factor; Belongs to the heparin-binding growth factors family. (194 aa) | ||||
UBE3A | Ubiquitin-protein ligase E3A; E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. (907 aa) | ||||
H3B181_LATCH | Teneurin transmembrane protein 4. (1031 aa) | ||||
MMP13 | Matrix metallopeptidase 13. (467 aa) | ||||
SAV1 | Salvador family WW domain containing protein 1. (393 aa) | ||||
ARX | Aristaless related homeobox. (455 aa) | ||||
DDR2 | Discoidin domain receptor tyrosine kinase 2. (838 aa) | ||||
SMAD1 | Mothers against decapentaplegic homolog. (465 aa) | ||||
IFT80 | Intraflagellar transport 80. (780 aa) | ||||
LEP | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. Belongs to the leptin family. (169 aa) | ||||
IER3IP1 | Immediate early response 3 interacting protein 1. (82 aa) | ||||
HLX | H2.0 like homeobox. (384 aa) | ||||
PDLIM5 | PDZ and LIM domain 5. (629 aa) | ||||
DLL1 | Delta-like protein; Putative Notch ligand involved in the mediation of Notch signaling. (723 aa) | ||||
LOC102364365 | Natriuretic peptide A-like. (130 aa) | ||||
THBS3 | Thrombospondin 3. (930 aa) | ||||
LOC106703556 | Natriuretic peptide A-like. (129 aa) | ||||
JARID2 | Jumonji and AT-rich interaction domain containing 2. (906 aa) | ||||
DLL3 | Delta-like protein; Putative Notch ligand involved in the mediation of Notch signaling. (699 aa) | ||||
LOC102348760 | Uncharacterized protein. (782 aa) | ||||
LEPR | Leptin receptor. (1149 aa) | ||||
ECM1 | Uncharacterized protein. (366 aa) | ||||
FGF8 | Fibroblast growth factor; Belongs to the heparin-binding growth factors family. (213 aa) | ||||
TGFB2 | Transforming growth factor beta; Belongs to the TGF-beta family. (415 aa) | ||||
ZMPSTE24 | CAAX prenyl protease; Proteolytically removes the C-terminal three residues of farnesylated proteins; Belongs to the peptidase M48A family. (453 aa) | ||||
RARB | NR LBD domain-containing protein. (299 aa) | ||||
EVC | EvC ciliary complex subunit 1. (814 aa) | ||||
RARA | Retinoic acid receptor alpha. (505 aa) | ||||
ARID2 | AT-rich interaction domain 2. (1771 aa) | ||||
RAG2 | Recombination activating 2. (522 aa) | ||||
TGFBR2 | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] (585 aa) | ||||
DIPK2A | Divergent protein kinase domain 2A. (434 aa) | ||||
BNC2 | Basonuclin 2. (880 aa) | ||||
CER1 | CTCK domain-containing protein. (257 aa) | ||||
GATA6 | GATA binding protein 6. (503 aa) | ||||
ADRA1A | Adrenoceptor alpha 1A. (459 aa) | ||||
SMPD3 | Sphingomyelin phosphodiesterase 3. (657 aa) | ||||
LOC102356233 | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] (574 aa) | ||||
BNC2-2 | Uncharacterized protein. (124 aa) | ||||
TMEM38B | Transmembrane protein 38B. (302 aa) |